Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Cabaletta Bio, Inc. (CABA) had Income from Continuous Operations of $-167.86M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-167.86M |
|
-- |
|
-- |
|
$172.24M |
|
$-172.24M |
|
$4.38M |
|
$-167.86M |
|
$-167.86M |
|
$-167.86M |
|
|
Income from Continuous Operations |
$-167.86M |
$-167.86M |
|
$-167.86M |
|
$-172.24M |
|
$-159.92M |
|
79.90M |
|
79.90M |
|
$-2.10 |
|
$-2.10 |
|
| Balance Sheet Financials | |
$138.87M |
|
$1.92M |
|
$26.21M |
|
$165.08M |
|
$50.15M |
|
-- |
|
$2.88M |
|
$53.03M |
|
$112.05M |
|
$112.05M |
|
$112.05M |
|
100.48M |
|
| Cash Flow Statement Financials | |
$-131.08M |
|
$-50.27M |
|
$100.35M |
|
$163.96M |
|
$82.98M |
|
$-80.98M |
|
$20.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-132.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-149.80% |
|
-149.80% |
|
-101.68% |
|
-149.80% |
|
$1.12 |
|
$-1.66 |
|
$-1.64 |
|